HIGHLIGHTS
- who: Zhiwen Fu from the Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China have published the paper: Treatment-related adverse events associated with HER2-Targeted antibody-drug conjugates in clinical trials: a systematic review and meta-analysis, in the Journal: (JOURNAL)
- what: Although several previous publications have reported the meta-analysis result of T-DM1 that involved the treatment-related adverse events, there is lack of T-DXd and they were performed with the few number of included studies or were focused on the efficacy evaluation and some . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.